Request for Covid-19 Impact Assessment of this Report

Healthcare

North America Restriction Endonucleases Market by Manufacturers, Countries, Type and Application, Forecast to 2022

  • GLO1166555
  • 120 Pages
  • May 2017
  • Healthcare
Download Sample    Get Discount   
 
Restriction Endonuclease is an enzyme that cuts DNA at or near specific recognition nucleotide sequences known as restriction sites. They are the enzymes that are found in the bacteria and are harvested from them for their use in research and commercial aspects. Restriction enzymes are commonly classified into four types, which differ in their structure and whether they cut their DNA substrate at their recognition site, or if the recognition and cleavage sites are separate from one another.

Scope of the Report:

This report focuses on the Restriction Endonucleases in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application.

Market Segment by Manufacturers, this report covers

New England Biolabs

Thermo Fisher Scientific

Takara Bio

Illumina

Agilent Technologies

Roche

GE Healthcare

Promega Corporation

Qiagen

Jena Biosciences

Market Segment by Countries, covering

United States

Canada

Mexico

Market Segment by Type, covers

Type I

Type II

Type III

Type IV

Others

Market Segment by Applications, can be divided into

Academic & Research Institutes

Hospitals & Diagnostic Centers

Biopharmaceutical

Other

There are 15 Chapters to deeply display the North America Restriction Endonucleases market.

Chapter 1, to describe Restriction Endonucleases Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Restriction Endonucleases, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 4, to show the North America market by countries, covering United States, Canada and Mexico, with sales, revenue and market share of Restriction Endonucleases, for each country, from 2012 to 2017;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;

Chapter 7, 8 and 9, to analyze the segment market in United States, Canada and Mexico, by manufacturers, type and application, with sales, price, revenue and market share by manufacturers, types and applications;

Chapter 10, Restriction Endonucleases market forecast, by countries, type and application, with sales, price and revenue, from 2017 to 2022;

Chapter 11, to analyze the manufacturing cost, key raw materials and manufacturing process etc.

Chapter 12, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 13, to describe sales channel, distributors, traders, dealers etc.

Chapter 14 and 15, to describe Restriction Endonucleases Research Findings and Conclusion, Appendix, methodology and data source

Table of Contents

1 Market Overview

1.1 Restriction Endonucleases Introduction

1.2 Market Analysis by Type

1.2.1 Type I

1.2.2 Type II

1.2.3 Type III

1.2.4 Type IV

1.2.5 Others

1.3 Market Analysis by Applications

1.3.1 Academic & Research Institutes

1.3.2 Hospitals & Diagnostic Centers

1.3.3 Biopharmaceutical

1.3.4 Other

1.4 Market Analysis by Countries

1.4.1 United States Status and Prospect (2012-2022)

1.4.2 Mexico Status and Prospect (2012-2022)

1.4.3 Canada Status and Prospect (2012-2022)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 New England Biolabs

2.1.1 Profile

2.1.2 Restriction Endonucleases Type and Applications

2.1.2.1 Type 1

2.1.2.2 Type 2

2.1.3 New England Biolabs Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.1.4 Business Overview

2.1.5 New England Biolabs News

2.2 Thermo Fisher Scientific

2.2.1 Profile

2.2.2 Restriction Endonucleases Type and Applications

2.2.2.1 Type 1

2.2.2.2 Type 2

2.2.3 Thermo Fisher Scientific Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2.4 Business Overview

2.2.5 Thermo Fisher Scientific News

2.3 Takara Bio

2.3.1 Profile

2.3.2 Restriction Endonucleases Type and Applications

2.3.2.1 Type 1

2.3.2.2 Type 2

2.3.3 Takara Bio Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3.4 Business Overview

2.3.5 Takara Bio News

2.4 Illumina

2.4.1 Profile

2.4.2 Restriction Endonucleases Type and Applications

2.4.2.1 Type 1

2.4.2.2 Type 2

2.4.3 Illumina Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4.4 Business Overview

2.4.5 Illumina News

2.5 Agilent Technologies

2.5.1 Profile

2.5.2 Restriction Endonucleases Type and Applications

2.5.2.1 Type 1

2.5.2.2 Type 2

2.5.3 Agilent Technologies Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5.4 Business Overview

2.5.5 Agilent Technologies News

2.6 Roche

2.6.1 Profile

2.6.2 Restriction Endonucleases Type and Applications

2.6.2.1 Type 1

2.6.2.2 Type 2

2.6.3 Roche Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6.4 Business Overview

2.6.5 Roche News

2.7 GE Healthcare

2.7.1 Profile

2.7.2 Restriction Endonucleases Type and Applications

2.7.2.1 Type 1

2.7.2.2 Type 2

2.7.3 GE Healthcare Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7.4 Business Overview

2.7.5 GE Healthcare News

2.8 Promega Corporation

2.8.1 Profile

2.8.2 Restriction Endonucleases Type and Applications

2.8.2.1 Type 1

2.8.2.2 Type 2

2.8.3 Promega Corporation Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8.4 Business Overview

2.8.5 Promega Corporation News

2.9 Qiagen

2.9.1 Profile

2.9.2 Restriction Endonucleases Type and Applications

2.9.2.1 Type 1

2.9.2.2 Type 2

2.9.3 Qiagen Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9.4 Business Overview

2.9.5 Qiagen News

2.10 Jena Biosciences

2.10.1 Profile

2.10.2 Restriction Endonucleases Type and Applications

2.10.2.1 Type 1

2.10.2.2 Type 2

2.10.3 Jena Biosciences Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10.4 Business Overview

2.10.5 Jena Biosciences News

3 North America Restriction Endonucleases Market Competition, by Manufacturer

3.1 North America Restriction Endonucleases Sales and Market Share by Manufacturer (2016-2017)

3.2 North America Restriction Endonucleases Revenue and Market Share by Manufacturer (2016-2017)

3.3 North America Restriction Endonucleases Price by Manufacturers (2016-2017)

3.4 Market Concentration Rate

3.4.1 Top 3 Restriction Endonucleases Manufacturer Market Share

3.4.2 Top 5 Restriction Endonucleases Manufacturer Market Share

3.5 Market Competition Trend

4 North America Restriction Endonucleases Market Analysis by Countries

4.1 North America Restriction Endonucleases Sales Market Share by Countries

4.2 North America Restriction Endonucleases Sales by Countries (2012-2017)

4.3 North America Restriction Endonucleases Revenue (Value) by Countries (2012-2017)

5 North America Market Segmentation Restriction Endonucleases by Type

5.1 North America Restriction Endonucleases Sales, Revenue and Market Share by Type (2012-2017)

5.1.1 North America Restriction Endonucleases Sales and Market Share by Type (2012-2017)

5.1.2 North America Restriction Endonucleases Revenue and Market Share by Type (2012-2017)

5.2 Type I Sales Growth and Price

5.2.1 North America Type I Sales Growth (2012-2017)

5.2.2 North America Type I Price (2012-2017)

5.3 Type II Sales Growth and Price

5.3.1 North America Type II Sales Growth (2012-2017)

5.3.2 North America Type II Price (2012-2017)

5.4 Type III Sales Growth and Price

5.4.1 North America Type III Sales Growth (2012-2017)

5.4.2 North America Type III Price (2012-2017)

5.5 Type IV Sales Growth and Price

5.5.1 North America Type IV Sales Growth (2012-2017)

5.5.2 North America Type IV Price (2012-2017)

5.6 Others Sales Growth and Price

5.6.1 North America Others Sales Growth (2012-2017)

5.6.2 North America Others Price (2012-2017)

6 North America Market Segmentation Restriction Endonucleases by Application

6.1 North America Restriction Endonucleases Sales Market Share by Application (2012-2017)

6.2 Academic & Research Institutes Sales Growth (2012-2017)

6.3 Hospitals & Diagnostic Centers Sales Growth (2012-2017)

6.4 Biopharmaceutical Sales Growth (2012-2017)

6.5 Other Sales Growth (2012-2017)

7 United States Restriction Endonucleases Sales, Revenue, by Type, Application and Manufacturers

7.1 United States Restriction Endonucleases Revenue, Sales and Growth Rate (2012-2017)

7.2 United States Restriction Endonucleases Sales and Market Share by Type

7.3 United States Restriction Endonucleases Sales by Application (2012-2017)

7.4 United States Restriction Endonucleases Sales, Revenue and Market Share by Manufacturer

7.4.1 United States Restriction Endonucleases Sales and Market Share by Manufacturer

7.4.2 United States Restriction Endonucleases Revenue and Market Share by Manufacturer

7.5 United States Restriction Endonucleases Export and Import (2012-2017)

8 Canada Restriction Endonucleases Sales, Revenue, by Type, Application and Manufacturers

8.1 Canada Restriction Endonucleases Revenue, Sales and Growth Rate (2012-2017)

8.2 Canada Restriction Endonucleases Sales and Market Share by Type

8.3 Canada Restriction Endonucleases Sales by Application (2012-2017)

8.4 Canada Restriction Endonucleases Sales, Revenue and Market Share by Manufacturer

8.4.1 Canada Restriction Endonucleases Sales and Market Share by Manufacturer

8.4.2 Canada Restriction Endonucleases Revenue and Market Share by Manufacturer

8.5 Canada Restriction Endonucleases Export and Import (2012-2017)

9 Mexico Restriction Endonucleases Sales, Revenue, by Type, Application and Manufacturers

9.1 Mexico Restriction Endonucleases Revenue, Sales and Growth Rate (2012-2017)

9.2 Mexico Restriction Endonucleases Sales and Market Share by Type

9.3 Mexico Restriction Endonucleases Sales by Application (2012-2017)

9.4 Mexico Restriction Endonucleases Sales, Revenue and Market Share by Manufacturer

9.4.1 Mexico Restriction Endonucleases Sales and Market Share by Manufacturer

9.4.2 Mexico Restriction Endonucleases Revenue and Market Share by Manufacturer

9.5 Mexico Restriction Endonucleases Export and Import (2012-2017)

10 Restriction Endonucleases Market Forecast (2017-2022)

10.1 North America Restriction Endonucleases Sales, Revenue and Growth Rate (2017-2022)

10.2 Restriction Endonucleases Market Forecast by Countries (2017-2022)

10.2.1 United States Restriction Endonucleases Forecast (2017-2022)

10.2.2 Canada Restriction Endonucleases Forecast (2017-2022)

10.2.3 Mexico Restriction Endonucleases Forecast (2017-2022)

10.3 Restriction Endonucleases Market Forecast by Type (2017-2022)

10.4 Restriction Endonucleases Market Forecast by Application (2017-2022)

11 Restriction Endonucleases Manufacturing Cost Analysis

11.1 Restriction Endonucleases Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.1.2 Price Trend of Key Raw Materials

11.1.3 Key Suppliers of Raw Materials

11.1.4 Market Concentration Rate of Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.2.1 Raw Materials

11.2.2 Labor Cost

11.2.3 Manufacturing Expenses

11.3 Manufacturing Process Analysis of Restriction Endonucleases

12 Industrial Chain, Sourcing Strategy and Downstream Buyers

12.1 Restriction Endonucleases Industrial Chain Analysis

12.2 Upstream Raw Materials Sourcing

12.3 Raw Materials Sources of Restriction Endonucleases Major Manufacturers in 2016

12.4 Downstream Buyers

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Analyst Introduction

15.3 Data SourceList of Tables and Figures

Figure Restriction Endonucleases Picture

Table Product Specifications of Restriction Endonucleases

Figure North America Sales Market Share of Restriction Endonucleases by Types in 2016

Table Types of Restriction Endonucleases

Figure Type I Picture

Table Major Manufacturers of Type I

Figure Type II Picture

Table Major Manufacturers of Type II

Figure Type III Picture

Table Major Manufacturers of Type III

Figure Type IV Picture

Table Major Manufacturers of Type IV

Figure Others Picture

Table Major Manufacturers of Others

Table North America Restriction Endonucleases Sales Market Share by Applications in 2016

Table Applications of Restriction Endonucleases

Figure Academic & Research Institutes Picture

Figure Hospitals & Diagnostic Centers Picture

Figure Biopharmaceutical Picture

Figure Other Picture

Figure United States Restriction Endonucleases Revenue (Million USD) and Growth Rate (2012-2022)

Figure Mexico Restriction Endonucleases Revenue (Million USD) and Growth Rate (2012-2022)

Figure Canada Restriction Endonucleases Revenue (Million USD) and Growth Rate (2012-2022)

Table New England Biolabs Basic Information, Manufacturing Base and Competitors

Table New England Biolabs Restriction Endonucleases Type and Applications

Table New England Biolabs Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors

Table Thermo Fisher Scientific Restriction Endonucleases Type and Applications

Table Thermo Fisher Scientific Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Takara Bio Basic Information, Manufacturing Base and Competitors

Table Takara Bio Restriction Endonucleases Type and Applications

Table Takara Bio Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Illumina Basic Information, Manufacturing Base and Competitors

Table Illumina Restriction Endonucleases Type and Applications

Table Illumina Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Agilent Technologies Basic Information, Manufacturing Base and Competitors

Table Agilent Technologies Restriction Endonucleases Type and Applications

Table Agilent Technologies Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Roche Basic Information, Manufacturing Base and Competitors

Table Roche Restriction Endonucleases Type and Applications

Table Roche Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table GE Healthcare Basic Information, Manufacturing Base and Competitors

Table GE Healthcare Restriction Endonucleases Type and Applications

Table GE Healthcare Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Promega Corporation Basic Information, Manufacturing Base and Competitors

Table Promega Corporation Restriction Endonucleases Type and Applications

Table Promega Corporation Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Qiagen Basic Information, Manufacturing Base and Competitors

Table Qiagen Restriction Endonucleases Type and Applications

Table Qiagen Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Jena Biosciences Basic Information, Manufacturing Base and Competitors

Table Jena Biosciences Restriction Endonucleases Type and Applications

Table Jena Biosciences Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table North America Restriction Endonucleases Sales by Manufacturer (2016-2017)

Figure North America Restriction Endonucleases Sales Market Share by Manufacturer in 2016

Figure North America Restriction Endonucleases Sales Market Share by Manufacturer in 2017

Table North America Restriction Endonucleases Revenue by Manufacturer (2016-2017)

Figure North America Restriction Endonucleases Revenue Market Share by Manufacturer in 2016

Figure North America Restriction Endonucleases Revenue Market Share by Manufacturer in 2017

Table North America Restriction Endonucleases Price by Manufacturers (2016-2017)

Figure Top 3 Restriction Endonucleases Manufacturer Market Share in 2016

Figure Top 3 Restriction Endonucleases Manufacturer Market Share in 2017

Figure Top 5 Restriction Endonucleases Manufacturer Market Share in 2016

Figure Top 5 Restriction Endonucleases Manufacturer Market Share in 2017

Figure North America Restriction Endonucleases Sales and Growth (2012-2017)

Table North America Restriction Endonucleases Sales by Countries (2012-2017)

Table North America Restriction Endonucleases Sales Market Share by Countries (2012-2017)

Figure North America 2012 Restriction Endonucleases Sales Market Share by Countries

Figure North America 2016 Restriction Endonucleases Sales Market Share by Countries

Figure North America Restriction Endonucleases Revenue and Growth (2012-2017)

Table North America Restriction Endonucleases Revenue by Countries (2012-2017)

Table North America Restriction Endonucleases Revenue Market Share by Countries (2012-2017)

Table North America 2012 Restriction Endonucleases Revenue Market Share by Countries

Table North America 2016 Restriction Endonucleases Revenue Market Share by Countries

Table North America Restriction Endonucleases Sales by Type (2012-2017)

Table North America Restriction Endonucleases Sales Share by Type (2012-2017)

Table North America Restriction Endonucleases Revenue by Type (2012-2017)

Table North America Restriction Endonucleases Revenue Share by Type (2012-2017)

Figure North America Type I Sales Growth (2012-2017)

Figure North America Type I Price (2012-2017)

Figure North America Type II Sales Growth (2012-2017)

Figure North America Type II Price (2012-2017)

Figure North America Type III Sales Growth (2012-2017)

Figure North America Type III Price (2012-2017)

Figure North America Type IV Sales Growth (2012-2017)

Figure North America Type IV Price (2012-2017)

Figure North America Others Sales Growth (2012-2017)

Figure North America Others Price (2012-2017)

Table North America Restriction Endonucleases Sales by Application (2012-2017)

Table North America Restriction Endonucleases Sales Share by Application (2012-2017)

Figure North America Academic & Research Institutes Sales Growth (2012-2017)

Figure North America Hospitals & Diagnostic Centers Sales Growth (2012-2017)

Figure North America Biopharmaceutical Sales Growth (2012-2017)

Figure North America Other Sales Growth (2012-2017)

Figure United States Restriction Endonucleases Revenue and Growth (2012-2017)

Figure United States Restriction Endonucleases Sales and Growth (2012-2017)

Table United States Restriction Endonucleases Sales by Type (2012-2017)

Table United States Restriction Endonucleases Sales Market Share by Type (2012-2017)

Table United States Restriction Endonucleases Sales by Application (2012-2017)

Table United States Restriction Endonucleases Sales Market Share by Application (2012-2017)

Table United States Restriction Endonucleases Sales by Manufacturer (2016-2017)

Figure United States Restriction Endonucleases Sales Market Share by Manufacturer in 2016

Figure United States Restriction Endonucleases Sales Market Share by Manufacturer in 2017

Table United States Restriction Endonucleases Revenue by Manufacturer (2016-2017)

Figure United States Restriction Endonucleases Revenue Market Share by Manufacturer in 2016

Figure United States Restriction Endonucleases Revenue Market Share by Manufacturer in 2017

Table United States Restriction Endonucleases Export and Import (2012-2017)

Figure Canada Restriction Endonucleases Revenue and Growth (2012-2017)

Figure Canada Restriction Endonucleases Sales and Growth (2012-2017)

Table Canada Restriction Endonucleases Sales by Type (2012-2017)

Table Canada Restriction Endonucleases Sales Market Share by Type (2012-2017)

Table Canada Restriction Endonucleases Sales by Application (2012-2017)

Table Canada Restriction Endonucleases Sales Market Share by Application (2012-2017)

Table Canada Restriction Endonucleases Sales by Manufacturer (2016-2017)

Figure Canada Restriction Endonucleases Sales Market Share by Manufacturer in 2016

Figure Canada Restriction Endonucleases Sales Market Share by Manufacturer in 2017

Table Canada Restriction Endonucleases Revenue by Manufacturer (2016-2017)

Figure Canada Restriction Endonucleases Revenue Market Share by Manufacturer in 2016

Figure Canada Restriction Endonucleases Revenue Market Share by Manufacturer in 2017

Table Canada Restriction Endonucleases Export and Import (2012-2017)

Figure Mexico Restriction Endonucleases Revenue and Growth (2012-2017)

Figure Mexico Restriction Endonucleases Sales and Growth (2012-2017)

Table Mexico Restriction Endonucleases Sales by Type (2012-2017)

Table Mexico Restriction Endonucleases Sales Market Share by Type (2012-2017)

Table Mexico Restriction Endonucleases Sales by Application (2012-2017)

Table Mexico Restriction Endonucleases Sales Market Share by Application (2012-2017)

Table Mexico Restriction Endonucleases Sales by Manufacturer (2016-2017)

Figure Mexico Restriction Endonucleases Sales Market Share by Manufacturer in 2016

Figure Mexico Restriction Endonucleases Sales Market Share by Manufacturer in 2017

Table Mexico Restriction Endonucleases Revenue by Manufacturer (2016-2017)

Figure Mexico Restriction Endonucleases Revenue Market Share by Manufacturer in 2016

Figure Mexico Restriction Endonucleases Revenue Market Share by Manufacturer in 2017

Table Mexico Restriction Endonucleases Export and Import (2012-2017)

Figure North America Restriction Endonucleases Sales, Revenue and Growth Rate (2017-2022)

Table North America Restriction Endonucleases Sales Forecast by Countries (2017-2022)

Table North America Restriction Endonucleases Market Share Forecast by Countries (2017-2022)

Figure United States Restriction Endonucleases Sales Forecast (2017-2022)

Figure Canada Restriction Endonucleases Sales Forecast (2017-2022)

Figure Mexico Restriction Endonucleases Sales Forecast (2017-2022)

Table North America Restriction Endonucleases Sales Forecast by Type (2017-2022)

Table North America Restriction Endonucleases Market Share Forecast by Type (2017-2022)

Table North America Restriction Endonucleases Sales Forecast by Application (2017-2022)

Table North America Restriction Endonucleases Market Share Forecast by Application (2017-2022)

Table Sales Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Restriction Endonucleases

Figure Manufacturing Process Analysis of Restriction Endonucleases

Figure Restriction Endonucleases Industrial Chain Analysis

Table Raw Materials Sources of Restriction Endonucleases Major Manufacturers in 2016

Table Major Buyers of Restriction Endonucleases

Table Distributors/Traders/ Dealers List

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Regenerative Medicine Market by Product Type (Cell Therapy, Gene Therapy, Tissue Engineering, and Small Molecule & Biologic), Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, and Pharmaceutical), and Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...

  • Publish Date: May 29, 2018
  • $5370
World Medical Robotics and Computer - Assisted Surgery Market - Opportunities and Forecasts, 2015 - 2022

The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...

  • Publish Date: May 1, 2016
  • $5370